Bandingkan Harga & Kinerja Midi Utama Indonesia Tbk. (MIDI) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Midi Utama Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Midi Utama Indonesia Tbk. diperdagangkan di Rp266 (kapitalisasi pasar 8,89 T, volume 24 jam 6,27 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Midi Utama Indonesia Tbk. jauh lebih besar — sekitar 85,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MIDI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 8,89 T | 104,4 M |
Volume | 6,27 jt | — |
Lot | 62,74 rb | — |
Perputaran | 1,67 M | — |
Harga Rata-rata | 266,81 | — |
Nilai Transaksi | 1,67 M | — |
Harga Ekuilibrium Indikatif | 266 | — |
Volume Ekuilibrium Indikatif | 237 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Midi Utama Indonesia Tbk.
PT Midi Utama Indonesia (the company) was established under its original name of PT Midimart Utama base on notarial deed No.37 of Mr Frans Elsius, S.H, dated on 28 Jun, 2007. The Company’s articles of association has been amended several times, most recently by notarial deed No. 2 of Kamelina, S.H., dated Mar 3, 2010, concerning among others, increase in capital paid up and public offering.
Selengkapnya di halaman MIDI →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
